Myoring Versus Keraring Implantation for Keratoconus

June 1, 2013 updated by: Zahra Rabbani Khah, Shahid Beheshti University of Medical Sciences

Various approaches, including surgical and non-surgical management have been proposed for keratoconus. One of the surgical procedures is Intrastromal Corneal Ring implantations that have been designed to achieve refractive readjustment by flattening the cornea. There are different models of Intrastromal Corneal rings available: intrastromal corneal ring segments (ICRS) such as Keraring and intrastromal corneal continuous ring (ICCR) like Myoring.

Most studies of these two types of ring implantation outcomes are retrospective case series. Thus, this Randomized Clinical Trial study was designed with the aim of Comparing visual and refractive outcomes and complications of insertion Myoring versus Keraring using Femtosecond laser. Keratoconus patients with compound myopic astigmatism who meet the inclusion criteria will randomly allocated to the Keraring and Myoring groups. Subsequently, the clinical outcomes of two groups will be compared at one,3 and 6 months after surgery.

Study Overview

Study Type

Interventional

Enrollment

23

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • keratoconus patients and :
  • age between 20 to 40
  • corneal thickness> 380 microns
  • mean keratometry between 44 to 60 D
  • clear central cornea
  • Patients should be discontinued their contact lenses for 3 weeks prior to the exams
  • contact lenses in tolerance
  • 20/200<visual acuity <20/30

Exclusion Criteria:

  • Positive pregnancy test
  • Breast-feeding
  • History of glaucoma, cataract, vernal and atopic keratoconjunctivitis
  • History of previous ophthalmologic surgery, keratorefractive surgery on the operative eye
  • Dry eye
  • Corneal stromal disorders
  • History of herpetic keratitis
  • Pellucid marginal degeneration
  • Corneal grafts
  • Retinal disorders
  • Nystagmus and uncooperative disposition
  • Neuro-ophthalmologic disorders
  • Intraocular pressure <10 mmHg or >21 mmHg
  • Patients with autoimmune, connective tissue disorders, diabetes and immunosuppressive drugs users
  • Hyperopia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Intrastromal corneal continuous ring (Myoring)
Active Comparator: Intrastromal corneal ring segments (Keraring)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
uncorrected visual acuity
Time Frame: 6 months
Snellen E chart
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Corneal thickness
Time Frame: 6months
Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)
6months
Corneal irregularities (3, 5 and 7 mm of central cornea)
Time Frame: 6 months
Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)
6 months
Front & back corneal elevation
Time Frame: 6 months
Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)
6 months
Corneal aberrometry
Time Frame: 6 months
Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)
6 months
Corneal eccentricity
Time Frame: 6 months
Galilei Dual Scheimpflug Analyzer ( Ziemer, Switzerland)
6 months
Corneal hysteresis & corneal resistance factor
Time Frame: 6 months

Ocular response Analyzer (reichert ophthalmic instruments, Buffalo,New York

,USA)

6 months
Intra and postoperative complications (glare, night vision problem, migration, extrusion, infection)
Time Frame: Intra and post operatien
clinical examination, patients history
Intra and post operatien

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Anticipated)

May 1, 2015

Study Registration Dates

First Submitted

May 22, 2013

First Submitted That Met QC Criteria

June 1, 2013

First Posted (Estimate)

June 5, 2013

Study Record Updates

Last Update Posted (Estimate)

June 5, 2013

Last Update Submitted That Met QC Criteria

June 1, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 91138

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratoconus

Clinical Trials on Intrastromal corneal continuous ring (Myoring) implantation

Subscribe